Friday, March 17, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

MERS-CoV Likely Began in Bats, Moved to Camels, Then People

by Global Biodefense Staff
March 1, 2016
MERS CoV Coronavirus

MERS-CoV particles on camel epithelial cells. Credit: NIAID in collaboration with Colorado State University

Middle East respiratory syndrome coronavirus (MERS-CoV) or its immediate ancestor most likely originated in a yet-unidentified bat species, according to National Institutes of Health (NIH), Colorado State University (CSU) and University of Northern Colorado (UNC) researchers.

Evidence of several closely related coronaviruses have been found in many bat species in Africa, Asia, the Americas and Eurasia, suggesting potential for widespread distribution of MERS-CoV-related viruses.

A new study published in Scientific Reports suggests bats are the most likely ancestral MERS-CoV reservoir, but at some point the virus spilled over into dromedary camels, which have developed from an intermediate to a primary host reservoir for the virus. Scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and CSU performed the study.

In 2012 MERS-CoV emerged in people in the Middle East and has since been found in six Arabian Peninsula countries. Cases spread by people traveling through Middle Eastern countries have been found in Europe, Asia, Africa and North America. As of Feb. 9, the World Health Organization had been notified of 1,638 MERS-CoV cases globally, including 587 deaths.

Shortly after MERS-CoV emerged scientists began suspecting that bats and/or dromedary camels played a transmission role, but little research since then has involved bats. In the NIAID-CSU study, scientists inoculated 10 Jamaican fruit bats with MERS-CoV. Each became infected, and some shed virus from the throat and rectum, but none showed clinical signs of disease. The study importantly shows the ability of MERS-CoV to replicate in bats without causing disease.

The research group from NIAID’s Rocky Mountain Laboratories is continuing to investigate how those viruses replicate in bats and move directly or via other species into people. Understanding those mechanisms could lead to the development of intervention strategies to stop the introduction of these viruses in the human population.

Tags: CoronavirusEmerging ThreatsMERS-CoVNIH

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks
Pathogens

NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks

December 7, 2022
Bat Virus Receptor Studies Vital to Predict Spillover Risk
Pathogens

Bat Virus Receptor Studies Vital to Predict Spillover Risk

December 7, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy